These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15678272)

  • 1. Myocardial infarction and arterial thrombosis in severe (homozygous) FXII deficiency: no apparent causative relation.
    Girolami A; Morello M; Girolami B; Lombardi AM; Bertolo C
    Clin Appl Thromb Hemost; 2005 Jan; 11(1):49-53. PubMed ID: 15678272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The occasional venous thromboses seen in patients with severe (homozygous) FXII deficiency are probably due to associated risk factors: a study of prevalence in 21 patients and review of the literature.
    Girolami A; Randi ML; Gavasso S; Lombardi AM; Spiezia F
    J Thromb Thrombolysis; 2004 Apr; 17(2):139-43. PubMed ID: 15306750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic events in severe FXII deficiency in comparison with unaffected family members during a long observation period.
    Girolami A; Ferrari S; Cosi E; Girolami B; Randi ML
    J Thromb Thrombolysis; 2019 Apr; 47(3):481-485. PubMed ID: 30694429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterozygous FXII deficiency is not associated with an increased incidence of thrombotic events: Results of a long term study.
    Girolami A; Ferrari S; Cosi E; Randi ML
    Blood Cells Mol Dis; 2019 Jul; 77():8-11. PubMed ID: 30884321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reevaluation of the incidence of thromboembolic complications in congenital factor XII deficiency--a study on 73 subjects from 14 Swiss families.
    Zeerleder S; Schloesser M; Redondo M; Wuillemin WA; Engel W; Furlan M; Lämmle B
    Thromb Haemost; 1999 Oct; 82(4):1240-6. PubMed ID: 10544906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of factor XII deficiency in 103 orally anticoagulated outpatients suffering from recurrent venous and/or arterial thromboembolism.
    Halbmayer WM; Mannhalter C; Feichtinger C; Rubi K; Fischer M
    Thromb Haemost; 1992 Sep; 68(3):285-90. PubMed ID: 1440493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding.
    Revenko AS; Gao D; Crosby JR; Bhattacharjee G; Zhao C; May C; Gailani D; Monia BP; MacLeod AR
    Blood; 2011 Nov; 118(19):5302-11. PubMed ID: 21821705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancies and oral contraceptive therapy in severe (homozygons) FXII deficiency: a study in 12 patients and review of the literature.
    Girolami A; Zocca N; Girolami B; Lombardi AM; Fabris F
    J Thromb Thrombolysis; 2004 Dec; 18(3):209-12. PubMed ID: 15815884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of a mild FXII deficiency with myocardial infarction and venous thrombosis is completely unjustified.
    Girolami A; Scarparo P; Vettore S
    J Thromb Thrombolysis; 2009 May; 27(4):454-5. PubMed ID: 19283451
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparable levels of activity and antigen in factor XII deficiency: a study of 21 homozygotes and 58 heterozygotes.
    Girolami A; Gavasso S; Pacquola E; Cabrio L; Lombardi AM; Girolami B
    Clin Appl Thromb Hemost; 2005 Jul; 11(3):335-8. PubMed ID: 16015420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic study in patients with factor XII deficiency: a report of three new mutations exon 13 (Q501STOP), exon 14 (P547L) and -13C>T promoter region in three compound heterozygotes.
    Lombardi AM; Bortoletto E; Scarparo P; Scapin M; Santarossa L; Girolami A
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):639-43. PubMed ID: 18832903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel homozygous missense mutation (Met527Ile) in a consanguineous marriage family with inherited factor XII deficiency.
    Liu M; Wang H; Lin M; Jin Y; Yang L; Wang M
    Hematology; 2020 Dec; 25(1):502-506. PubMed ID: 33317433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptomatic combined homozygous factor XII deficiency and heterozygous factor V Leiden. luscaber@tin.it.
    Girolami A; Simioni P; Scarano L; Girolami B; Zerbinati P
    J Thromb Thrombolysis; 2000 Apr; 9(3):271-5. PubMed ID: 10728027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hereditary deficiency of antithrombin III, protein C, protein S and factor XII in 121 patients with venous or arterial thrombosis].
    Miljić P; Rolović Z; Elezović I; Antunović P; Stanojević M; Colović M
    Srp Arh Celok Lek; 1999; 127(1-2):21-7. PubMed ID: 10377836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Factor XII (Hageman factor) deficiency: a risk factor for development of thromboembolism. Incidence of factor XII deficiency in patients after recurrent venous or arterial thromboembolism and myocardial infarction].
    Halbmayer WM; Mannhalter C; Feichtinger C; Rubi K; Fischer M
    Wien Med Wochenschr; 1993; 143(2):43-50. PubMed ID: 8488686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hageman factor deficiency (factor XII)--hemorrhage or thrombosis?].
    Schott G; Lutze G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(3):436-41. PubMed ID: 2414173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic analysis of a hereditary factor XII deficiency pedigree of a consanguineous marriage due to a homozygous F12 gene mutation: Gly341Arg.
    Cheng X; Yang L; Huang G; Jin Y; Hao X; Wang M
    Hematology; 2017 Jun; 22(5):310-315. PubMed ID: 28007010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation.
    Kokoye Y; Ivanov I; Cheng Q; Matafonov A; Dickeson SK; Mason S; Sexton DJ; Renné T; McCrae K; Feener EP; Gailani D
    Thromb Res; 2016 Apr; 140():118-124. PubMed ID: 26950760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A common C-->T polymorphism at nt 46 in the promoter region of coagulation factor XII is associated with decreased factor XII activity.
    Endler G; Exner M; Mannhalter C; Meier S; Ruzicka K; Handler S; Panzer S; Wagner O; Quehenberger P
    Thromb Res; 2001 Feb; 101(4):255-60. PubMed ID: 11248286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Increased risk of thrombosis in FXII deficiency?].
    Bylesjö I; Jansson JH; Schulman S
    Lakartidningen; 1995 Feb; 92(5):425. PubMed ID: 7853920
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.